News Category: Industry News

The pandemic has resulted in unprecedented levels of demand for device testing with requests for rapid turnaround times. Read More

In the risk management phase of medical device development, having as much information as possible about every input into the final product is critical – from raw materials and manufacturing additives, to the ways in which cleaning or sterilization affect material properties. Read More

Changes in testing protocols and revised regulatory demands make testing experts even more valuable than they’ve ever been. Read More

We hope that this message finds you well. As the world moves into a variety of different reopening phases, we wanted to take a moment to reiterate our commitment to you during this difficult time. As an essential business, Toxikon has continued to operate safely and effectively since the beginning of the COVID-19 pandemic. As […]

During this ongoing COVID-19 pandemic, Toxikon has continued to work hard to serve industry as a single-source provider for preclinical safety and efficacy testing to ensure healthcare products can reach patients. To protect our workforce and minimize disruptions to the business, we have put into effect flexible scheduling for our employees and full COVID-19 safety […]

We know now more than ever with the COVID-19 crisis that the essential services we provide our customers have never been more critical. Toxikon is working diligently to continue to serve as your single-source provider for preclinical safety and efficacy testing to ensure your healthcare products can reach patients. We remain committed to supporting the […]

With the ongoing COVID-19 pandemic, we are continuing to update you on any changes or impacts at Toxikon relative to the services we provide our customers world-wide. Starting today, March 24th, Massachusetts enacted a closing of non-essential businesses until April 7th to minimize the potential spread of COVID-19. As a life science company supporting the […]

This roundtable discussion examines the technological and regulatory factors affecting the third-party testing and analysis services industry.

Toxikon Corporation, a leading global preclinical contract research organization (CRO), has launched a new website at www.toxikon.com, targeted towards scientists, engineers, and regulatory professionals involved in developing and commercializing medical devices, pharmaceuticals, and biologic products. “For more than 40 years, Toxikon has shown that quality science and ongoing education are key to quickly and successfully […]

Toxikon is pleased to announce that effective 1 September 2018, we have reopened its European office in Almelo, The Netherlands, to better support our growing and existing European customers, which began with Toxikon Europe over 28 years ago. A dedicated client relations and sample management team will offer localized service for sponsors throughout Europe, including […]